Determining a Treatment Threshold Value for Endometrial Thickness in Women with Breast Cancer Receiving Tamoxifen
International Journal of Women's Health · 2025-09 · Volume 17 · 3189-3199
DOI: 10.2147/ijwh.s531872 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Women's Health, 2025-09. Verfasst von Lurong Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 3610…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Breast cancer is a prevalent malignancy in women that often requires endocrine treatment, such as tamoxifen, which is known to affect endometrial thickness and pose risks of endometrial pathologies.
Objective
This study aimed to determine a clinically relevant threshold for transvaginal ultrasound-measured endometrial thickness in breast cancer patients receiving tamoxifen therapy and assess its predictive value for endometrial pathologies.
Methods
We analyzed a total of 205 endometrial biopsies from women dichotomized into premenopausal and postmenopausal groups. We assessed the clinical and pathological characteristics in relation to the presence of endometrial pathologies, employing receiver operating characteristic (ROC) curves to evaluate the predictive value of endometrial thickness as a diagnostic marker.
Results
Among the study cohort, 11.71% of patients were diagnosed with endometrial hyperplasia, and 3.90% had endometrial cancer. Our findings indicate that women with endometrial pathologies exhibited significantly greater endometrial thickness (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361000, People's Republic of China.
ORCID-Profile: Jian An
Zitieren
APA
Huang, L., Lu, Y., Chen, Y., Liu, H., & An, J. (2025). Determining a Treatment Threshold Value for Endometrial Thickness in Women with Breast Cancer Receiving Tamoxifen. International Journal of Women's Health, Volume 17, 3189-3199. https://doi.org/10.2147/ijwh.s531872
Vancouver
Huang L, Lu Y, Chen Y, Liu H, An J. Determining a Treatment Threshold Value for Endometrial Thickness in Women with Breast Cancer Receiving Tamoxifen. International Journal of Women's Health. 2025;Volume 17:3189-3199. doi:10.2147/ijwh.s531872
BibTeX
@article{Huang2025,
author = {Huang, Lurong and Lu, Ye and Chen, Yanhui and Liu, Hongli and An, Jian},
title = {Determining a Treatment Threshold Value for Endometrial Thickness in Women with Breast Cancer Receiving Tamoxifen},
journal = {International Journal of Women's Health},
year = {2025},
volume = {Volume 17},
pages = {3189--3199},
doi = {10.2147/ijwh.s531872}
}
EUVIMED